Safety Study of Live Attenuated Influenza Vaccine, CodaVax
Clinical trial NCT03926416 · COMPLETED
Trial details
- NCT number
- NCT03926416
- Sponsor
- Codagenix, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2018-05-29
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.